FC
BIIB icon

Financial Consulate’s Biogen BIIB Stock Holding History

Financial Consulate’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Buy
23
+12
+109% +$2.29K ﹤0.01% 854
2026
Q1 		$2.02K Buy
11
+7
+175% +$1.29K ﹤0.01% 979
2025
Q4 		$704 Hold
4
– – ﹤0.01% 1087
2025
Q3 		$561 Buy
+4
New +$541 ﹤0.01% 965

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Consulate's BIIB Position: Q2 2026 in Review

Financial Consulate increased its Biogen (BIIB) stake by 109% in Q2 2026, buying an estimated $2.29K and bringing the position to 23 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #854.

Financial Consulate first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Financial Consulate held 23 shares of Biogen worth $4.97K as of Q2 2026.
  • Financial Consulate bought 12 Biogen shares in Q2 2026, an estimated $2.29K.
  • Biogen made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #854 holding.
  • Financial Consulate first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.